RSF Bio is a clinical stage, calcific disorders platform company based in San Diego. Company’s lead technology was developed by Sanofi and Mayo Clinic and involves the selective re-activation of nitric oxide in diseased tissue. Their first drug, Ataciguat is entering into Phase III clinical trials.